| Title： | Chinese guidelines for the diagnosis and treatment of systemic juvenile idiopathic arthritis |
| Edition： | Original |
| Classification： | Standard guideline |
| Field： | Diagnosis and Treatment |
| Countries and regions： | China |
| Guidelines users： | Pediatric rheumatologists, relevant researchers involved in the treatment and management of SJIA at all levels of hospitals are the population for whom this guideline in intended. |
| Evidence classification method： | GRADE (Grading of Recommendations Assessment, Development and Evaluation) methodology was used to rate the quality of evidence and the strength of recommendation. |
| Development unit： | The subspecialty Group of Immunology, the society of Pediatrics, Chinese Medical Association |
| Registration time: | 2022-09-21 |
| Registration number： | PREPARE-2022CN614 |
| Purpose of the guideline: | This guideline is intended to provide recommendations for the standardized diagnosis, evidence-based pharmacologic treatment strategies of systemic juvenile idiopathic arthritis. |
